Specialty Pharmacy News

Image description

J&J: 10 products with “blockbuster potential” to be filed by 2021

During an analyst meeting, the company also said it will share its plans to continue driving sustainable growth by leveraging its strong portfolio of core blockbuster products, the “industry-leading” productivity of its innovation model, and the pending acquisition of Swiss-based biotech company Actelion.